Patents by Inventor R. Sanders Williams

R. Sanders Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7629308
    Abstract: The present invention relates to the polypeptides known as muscle calcineurin interacting proteins (MCIPs). These molecules binding to calcineurin and, in so doing, modulate its functions, which includes phosphate removal as part of a pathway coupling Ca2+ to cellular responses in muscle. MCIPs form a physical complex with the catalytic subunit of calcineurin, and increased levels of MCIPs correspond to a reduced ability of calcineurin to stimulate transcription of certain target genes. Methods to exploit these observation are provided and include screening for modulators of MCIP expression and binding to calcineurin, methods of diagnosis of MCIP defects, and methods for treating cardiomyopathies, including cardiac hypertrophy.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: December 8, 2009
    Assignee: Board of Regents, The University of Texas System
    Inventors: R. Sanders Williams, Beverly Rothermel
  • Publication number: 20040003424
    Abstract: The present invention provides methods for creating conditionally-immortal cell lines. These transgenic cell lines can be grown indefinitely in culture while maintaining a relatively undifferentiated stated. Upon appropriate switch signal, the cells cease replicating and differentiate much like adult cells. The switch is facilitated by the inactivation of a transforming gene, such as large T antigen. A convenient methodology for such inactivation is Cre-Lox mediated excision of the gene. Cardiac cells are provided as an example of useful a transgenic cell line.
    Type: Application
    Filed: March 4, 2003
    Publication date: January 1, 2004
    Applicant: Board of Regents, The University of Texas System
    Inventors: Eric Olson, Rhonda Bassel-Duby, David W. Markham, Igor I. Rybkin, R. Sanders Williams
  • Publication number: 20020150953
    Abstract: The present invention relates to the polypeptides known as muscle calcineurin interacting proteins (MCIPs). These molecules binding to calcineurin and, in so doing, modulate its functions, which includes phosphate removal as part of a pathway coupling Ca2+ to cellular responses in muscle. MCIPs form a physical complex with the catalytic subunit of calcineurin, and increased levels of MCIPs correspond to a reduced ability of calcineurin to stimulate transcription of certain target genes. Methods to exploit these observation are provided and include screening for modulators of MCIP expression and binding to calcineurin, methods of diagnosis of MCIP defects, and methods for treating cardiomyopathies, including cardiac hypertropy.
    Type: Application
    Filed: February 13, 2001
    Publication date: October 17, 2002
    Inventors: R. Sanders Williams, Beverly Rothermel
  • Patent number: 6361954
    Abstract: The invention pertains to novel genes which function in the regulation of DNA replication and/or entry of a cell into mitosis. Tile invention also pertains to novel proteins encoded by the genes described herein, antibodies which bind the encoded protein, and homologs of the novel genes which function in regulation of DNA replication and/or entry of a cell into mitosis find hybridize to the DNA sequence of the novel genes. The invention also includes methods for determining the presence of a proliferative disorder comprising determining the presence of level of hscdc6.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: March 26, 2002
    Assignees: Cold Spring Harbor Laboratory, The University of Texas System
    Inventors: Bruce Stillman, R. Sanders Williams, Juan R. Mendez
  • Patent number: 6194389
    Abstract: A method of transferring a gene to vertebrate cells is disclosed. The method comprises the steps of: (a) providing microprojectiles, the microprojectiles carrying polynucleic acid sequences, the sequences comprising, in the 5′ to 3′ direction, a regulatory sequence operable in the tissue cells and a gene positioned downstream of the regulatory sequence and under the transcriptional control thereof; and (b) accelerating the microprojectiles at the cells, with the microprojectiles contacting the cells at a speed sufficient to penetrate the cells and deposit the polynucleic acid sequences therein. Preferably, the target cells reside in situ in the animal subject when they are transformed. Preferred target cells are dermis or hypodermis cells, and preferred genes for insertion into the target cells are genes which code for proteins or peptides which produce a physiological response in the animal subject.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: February 27, 2001
    Assignees: Duke University, E.I. du Pont de Nemours & Company, Inc, Cornell Research Foundation, Inc.
    Inventors: Stephen A. Johnston, R. Sanders Williams, John C. Sanford, Sandra G. McElligott
  • Patent number: 6074819
    Abstract: The invention pertains to novel genes which function in the regulation of DNA replication and/or entry of a cell into mitosis. The invention also pertains to novel proteins encoded by the genes described herein, antibodies which bind the encoded protein, and homologs of the novel genes which function in regulation of DNA replication and/or entry of a cell into mitosis and hybridize to the DNA sequence of the novel genes.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: June 13, 2000
    Assignees: Cold Spring Harbor Laboratory, Board of Regents, The University of Texas Systems
    Inventors: Bruce Stillman, R. Sanders Williams
  • Patent number: 5851821
    Abstract: The invention pertains to novel genes which function in the regulation of DNA replication and/or entry of a cell into mitosis. The invention also pertains to novel proteins encoded by the genes described herein, antibodies which bind the encoded protein, and homologs of the novel genes which function in regulation of DNA replication and/or entry of a cell into mitosis and hybridize to the DNA sequence of the novel genes.
    Type: Grant
    Filed: May 2, 1996
    Date of Patent: December 22, 1998
    Assignees: Cold Spring Harbor Laboratory, The Board of Regents, The University of Texas System
    Inventors: R. Sanders Williams, Bruce Stillman
  • Patent number: 5569754
    Abstract: The invention relates to small RNAs encoded within the nucleus of mammalian cells that specifically import to the mitochondria. The RNAs bind to several nucleolar peptides and thus provide potential carriers for import of biological molecules, including metabolites and proteins, into the mitochondrial compartment. Mitochondrial dysfunction in several maternally inherited human diseases may be correctable employing linkage of mitochondrial import signal to mitochondrial tRNA sequences expressed from nuclear trans-genes without requirement for direct genetic transformation of mitochondria.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: October 29, 1996
    Assignee: Board of Regents, University of TX Systems
    Inventors: R. Sanders Williams, Kang Li